ImmuneBridge Company

ImmuneBridge is developing allogeneic immunotherapies for cancer.

Investors

Technology: Cell therapy
Industry: Private
Headquarters: San Francisco, California, United States
Founded Date: 2018-01-01
Employees Number: 1-10
Investors Number: 1
Total Funding: 10150000
Last Funding Date: 2023-01-09
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership